Pancreatic fistula medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Pancreatic_fistula}} {{CMG}} ==Overview== ==Medical Therapy== The production of pancreatic enzymes is suppressed by restricting the patient's oral intake of food...") |
(No difference)
|
Revision as of 22:22, 4 September 2012
Pancreatic fistula Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pancreatic fistula medical therapy On the Web |
American Roentgen Ray Society Images of Pancreatic fistula medical therapy |
Risk calculators and risk factors for Pancreatic fistula medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
The production of pancreatic enzymes is suppressed by restricting the patient's oral intake of food patient in conjunction with the use of long-acting somatostatin analogues[1]. The patient's nutrition is maintained by total parenteral nutrition. This treatment is continued for 2-3 weeks, and the patient is observed for improvement.
References
- ↑ Takeo C, Myojo S (2000). "Marked effect of octreotide acetate in a case of pancreatic pleural effusion". Curr Med Res Opin. 16 (3): 171–7. PMID 11191006.